His work focuses on how microbial ecosystems interact with human physiology, including: Gut barrier function and intestinal permeability Mucus-associated microbiota (Akkermansia-related systems) Oralgut microbiome axis Short-chain fatty acids (SCFAs) and metabolic signaling Circadian rhythmmicrobiome interactions Clinical Research Contributions He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including: Active Ulcerative Colitis (Inflammatory Bowel Disease) Hyperoxaluria (Oxalate Metabolism Disorder) Microbiome-driven gut health and inflammatory conditions These studies were part of broader clinical development programs evaluating microbiome-based approaches
Cch bo qun thuc Semaglutide Bt tim Semaglutide cha qua s dng c bo qun ngn mt ca t lnh (nhit t 2 8oC)
Herbal compounds, based on their components can stimulate GLP-1 secretion and provide glycemic control effects in T2DM in different ways
However, there was no significant improvement in fibrosis stage by semaglutide therapy
Alarmingly, some individuals undergo multiple additional bariatric procedures, including conversional or revisional surgeries [17], to address these outcomes
When insulin sensitivity is optimized through GIP activity, muscle tissue becomes more responsive to this anabolic signal while fat cells become less efficient at storing excess calories
